New cancer drugs being held back to save Government money, says GlaxoSmithKline boss

The head of Britain biggest drugs company has accused the Government of systematically delaying the introduction of new cancer drugs in order to save money.
The Telegraph
Mar. 01, 2012

Popular
FL State Sen. Randy Fine Celebrated Israel Killing an American - Trump Just Endorsed Him For Congress
Trump Nominates Pam Bondi for Attorney General
Netanyahu Cries 'Antisemitism' After International Criminal Court Issues Warrant for His Arrest
Matt Gaetz Withdraws from Consideration as Attorney General
FBI Pays Visit to Pro-Palestine Journalist Alison Weir's Home

GlaxoSmithKline chief executive Sir Andrew Witty warned that ministers were making false economies as they tried to grapple with the deficit in the public finances.

Read More